A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene.

Source:http://linkedlifedata.com/resource/pubmed/id/15131034

Clin. Cancer Res. 2004 May 1 10 9 2986-96

Download in:

View as

Triples

General Info

PMID
15131034